Related Experiment Video

Updated: Aug 2, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Healthcare resources and needs in anticoagulant therapy for patients with nonvalvular atrial fibrillation. SAMOA

V Barrios1, M I Egocheaga-Cabello2, J Gállego-Culleré3

  • 1Servicio de Cardiología, Hospital Ramón y Cajal, Madrid, España.

Revista Clinica Espanola
|February 19, 2017
PubMed

Insights

Physician surveys reveal significant gaps in standardized care and quality control for patients on anticoagulation therapy for nonvalvular atrial fibrillation. Improvements are needed in treatment protocols and direct-acting anticoagulant drug training.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Background:

  • Nonvalvular atrial fibrillation (NVAF) necessitates anticoagulation to prevent stroke.
  • Effective management of anticoagulated NVAF patients is crucial for optimal outcomes.
  • Understanding current healthcare processes and resource allocation is vital for improving patient care.

Purpose of the Study:

  • To assess the healthcare process for anticoagulated NVAF patients across medical specialties.
  • To identify available resources and pinpoint areas for improvement in patient management.
  • To evaluate the current landscape of anticoagulant therapy prescription and follow-up.

Main Methods:

  • A cross-sectional survey was conducted among primary care and specialized physicians.
  • Questionnaires focused on healthcare processes, anticoagulant therapy indications, prescription, and barriers.
  • Data from 893 physicians (437 primary care, 456 specialists) were analyzed.

Main Results:

  • 42% of family doctors assessed/prescribed anticoagulation; 66% managed patient follow-up.
  • Physicians reported a lack of standardized protocols in both primary and specialized care.
  • Deficiencies in treatment quality control were identified across healthcare settings.

Conclusions:

  • Primary care's role in managing anticoagulated patients has expanded.
  • Significant gaps exist in healthcare process standardization and patient follow-up for anticoagulated NVAF patients.
  • Enhanced training in direct-acting anticoagulant drugs is essential for improving care.
Abstract

Keywords:
Accidente cerebrovascularAnticoagulant therapyFibrilación auricular no valvularHaemorrhageHealthcare processHemorragiaNonvalvular atrial fibrillationPrevención secundariaProceso asistencialSecondary preventionStrokeTratamiento anticoagulante

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Related Concept Videos

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
355
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
432
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
578